International | USA

About Us

Biotest Pharmaceuticals Corporation
5800 Park of Commerce Blvd., N.W.
Boca Raton, FL 33487
Toll free: 800-327-7106
Phone: 561-989-5800
Fax: 561-989-5801
E-mail: info@biotestpharma.com
Get a Map

Biotest Plasma Center
Website: www.biotestplasma.com
email: plasma@biotestpharma.com

Biotest AG - Corporate Offices

Biotest AG BuildingBiotest AG
Landsteinerstr. 5
63303 Dreieich
GERMANY

 



Tel: +49 (0)6103 801 0
Fax: +49 (0)6103 801 150

Website: www.biotest.de
Email: mail@biotest.de

 

 

From Nature for Life

Biotest Pharmaceuticals Corporation was created as a U.S. subsidiary of Biotest AG in December 2007. Innovative technologies and a sharp focus on safety are incorporated into every facet of the business. Biotest AG has a rich history in the development and manufacture of pharmaceutical and biotherapeutic products utilized in immunology and hematology. From plasma collection to product manufacturing and distribution – from nature for life – Biotest Pharmaceuticals Corporation is committed to maintaining these same high standards of excellence.

Biotest - A Rich History 

 

1860
Biotest AG traces its roots to 1860 when the Schleussner family starts a company to provide the chemicals needed in the new and emerging technology of photography.

1896
In cooperation with x-ray discoverer Wilhelm Conrad Rontgen, the company begins manufacturing the plates required to produce x-ray images.

 

1940s
 The Biotest Serum Institute is established by Dr. Hans Schleussner, great-grandson of the founder, to focus on blood typing serology.  The company introduces the typing sera for Rh (anti-D), and a new product Biseko, a plasma preparation for therapeutic use.

 1970s
Biotest introduces Intraglobin, a structurally complete and biologically intact IgG immunoglobulin; and Intraglobin F, a ready-to-use IgG.

1980s
Biotest offers hyper immunoglobulins (hyperimmunes), Hepatect (IgG – antiHBs), and two IV hyperimmunes: Varitect (IgG anti-VZV) and Cytotect (IgG anti-CMV). Pentaglobin®, an intravenouslytolerable IgM-enriched immunoglobulin is also introduced.

1990s
The company produces a double virus-inactivated factor VIII preparation (Haemoctin ® ) for persons with hemophilia.

2000s
Biotest introduces its fully automated blood typing system, and begins clinical testing of new monoclonal antibodies. The plasma protein business and the Biologics Business Unit of Nabi Biopharmaceuticals is acquired by Biotest AG in 2007.

Today
Biotest continues its principal mission of introducing new disease fighting therapies with a series of significant developmental products in its pipeline.